Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey

Özgür Kartal, Mustafa Güleç, Zafer Çalışkaner, Uğur Muşabak, Osman Şener

Immunopharmacology and Immunotoxicology · 2015 · 23 citations · 40 references

Abstract

The analysis of our data over a 30-year period confirmed that SCIT with inhalant allergens conducted strictly according to the standard protocols and when administrated by experienced staff is a safe method of treatment with only a few side-effects.

References

40